Perspectives on Deprescribing in Palliative Care

Overview

Journal Expert Rev Clin Pharmacol

Specialty Pharmacology

Date 2023 Mar 30

PMID 36995162

Authors

Jennifer Tjia

Maki Karakida

Matthew Alcusky

Jon P Furuno

Affiliations

Soon will be listed here.

Abstract

Introduction: Pharmacotherapy plays a critical role in the delivery of high-quality palliative care, but the intersection of palliative care and deprescribing has received little attention.

Areas Covered: We conducted a scoping review of English language articles using PubMed to identify relevant publications between 1 January 2000 to 31 July 2022 using search terms of deprescribing, palliative care, end of life, and hospice. We summarize current definitions and developments in palliative care and deprescribing from both clinical and research perspectives. We highlight key challenges and outline proposed solutions and needed research.

Expert Opinion: The future of deprescribing in palliative care requires the development and adoption of individualized approaches to medication management, including a reconsidered approach to communication about deprescribing. Evidence from high-quality clinical outcomes studies is lacking, and the field needs new approaches to coordination of care delivery. This review article will be of interest to both clinical and research-based pharmacists, physicians, and nurses interested in improving care for patients with serious illness.

Citing Articles

DEprescribing: Perceptions of PAtients living with advanced cancer. A multicentre, prospective mixed observational study protocol.

Evin A, Bourdon M, Nizet P, Hardouin J, Victorri-Vigneau C, Huon J PLoS One. 2024; 19(8):e0305737.

PMID: 39163415 PMC: 11335145. DOI: 10.1371/journal.pone.0305737.

References

Korenvain C, MacKeigan L, Dainty K, Guilcher S, McCarthy L . Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel. Res Social Adm Pharm. 2020; 16(12):1746-1753. DOI: 10.1016/j.sapharm.2020.01.019. View

Rochon P, Gurwitz J . The prescribing cascade revisited. Lancet. 2017; 389(10081):1778-1780. DOI: 10.1016/S0140-6736(17)31188-1. View

Ailabouni N, Weir K, Reeve E, Turner J, Wilson Norton J, Gray S . Barriers and enablers of older adults initiating a deprescribing conversation. Patient Educ Couns. 2021; 105(3):615-624. DOI: 10.1016/j.pec.2021.06.021. View

Cadogan C, Murphy M, Boland M, Bennett K, McLean S, Hughes C . Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review. Explor Res Clin Soc Pharm. 2022; 3:100050. PMC: 9031741. DOI: 10.1016/j.rcsop.2021.100050. View

Berard A . Pharmacoepidemiology Research-Real-World Evidence for Decision Making. Front Pharmacol. 2021; 12:723427. PMC: 8452957. DOI: 10.3389/fphar.2021.723427. View

Bregnhoj L, Thirstrup S, Kristensen M, Bjerrum L, Sonne J . Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol. 2008; 65(2):199-207. DOI: 10.1007/s00228-008-0558-7. View

Bernacki R, Block S . Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014; 174(12):1994-2003. DOI: 10.1001/jamainternmed.2014.5271. View

Suhrie E, Hanlon J, Jaffe E, Sevick M, Ruby C, Aspinall S . Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother. 2009; 7(1):20-5. PMC: 4870890. DOI: 10.1016/j.amjopharm.2009.02.001. View

Bahat G, Ilhan B, Bay I, Kilic C, Kucukdagli P, Oren M . Explicit versus implicit evaluation to detect inappropriate medication use in geriatric outpatients. Aging Male. 2018; 23(3):179-184. DOI: 10.1080/13685538.2018.1464552. View

10.

Stevens E, Kim S, Leshner G, Leavens E, Vidrine J, Frank-Pearce S . The Attitudinal and Motivational Effects of Anti-waterpipe Messages. Am J Health Behav. 2019; 43(3):478-489. PMC: 6692900. DOI: 10.5993/AJHB.43.3.3. View

11.

Weissman J, Gazarian P, Reich A, Tjia J, Prigerson H, Sturgeon D . Recent Trends in the Use of Medicare Advance Care Planning Codes. J Palliat Med. 2020; 23(12):1568-1570. PMC: 7698819. DOI: 10.1089/jpm.2020.0437. View

12.

OMahony D, OConnor M . Pharmacotherapy at the end-of-life. Age Ageing. 2011; 40(4):419-22. DOI: 10.1093/ageing/afr059. View

13.

Rahme E, Choquette D, Beaulieu M, Bessette L, Joseph L, Toubouti Y . Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. Am J Med. 2005; 118(11):1262-70. DOI: 10.1016/j.amjmed.2005.03.026. View

14.

Reigada C, Arantzamendi M, Centeno C . Palliative care in its own discourse: a focused ethnography of professional messaging in palliative care. BMC Palliat Care. 2020; 19(1):88. PMC: 7310281. DOI: 10.1186/s12904-020-00582-5. View

15.

Brandt N, Cooke C . Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing Strategies for Improving Medication Use Among Beneficiaries Enrolled in Medicare Part D. Clin Geriatr Med. 2017; 33(2):153-164. DOI: 10.1016/j.cger.2017.01.001. View

16.

Krishnaswami A, Steinman M, Goyal P, Zullo A, Anderson T, Birtcher K . Deprescribing in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2019; 73(20):2584-2595. PMC: 6724706. DOI: 10.1016/j.jacc.2019.03.467. View

17.

Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M . The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Support Care Cancer. 2014; 23(1):71-8. DOI: 10.1007/s00520-014-2322-0. View

18.

Li Y, Whelan C, Husain A . Deprescribing in the Home Palliative Setting. J Palliat Med. 2020; 24(7):1030-1035. DOI: 10.1089/jpm.2020.0376. View

19.

Gardner E . Deprescribing in end-of-life care. Br J Community Nurs. 2019; 24(10):474-477. DOI: 10.12968/bjcn.2019.24.10.474. View

20.

Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom J, Ernecoff N, Hanmer J . Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis. JAMA. 2016; 316(20):2104-2114. PMC: 5226373. DOI: 10.1001/jama.2016.16840. View